Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04934137 · ClinicalTrials.gov registry record · NA
Development of Technologies to Increase In-Seat Movement to Prevent Sitting-Acquired Pressure Injuries in Wheelchair Users
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04934137: Completed NA study, sponsored by Mayo Clinic.
NCT04934137 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04934137, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Pressure-related injuries in individuals with SCI and persons who use wheelchairs are one of the most dangerous secondary health problems encountered throughout the lifespan. With recurrence rates as high as 79% and mortality rates as high as 48% when sepsis is present, there exists a critical clinical need to target prevention of pressure injuries. This study will examine the effects of two novel seat mapping technologies ("AW-Shift" and "Sensoria") on increasing in-seat movement in persons who may be at risk for pressure injuries due to altered sensation on their sitting surface. AW-Shift provides a visual display about pressure distribution directly between the body and the seat cushion to a wheelchair user outside of a clinical setting. Sensoria represents a novel technology to promote tissue health by providing users with information about their daily in-seat movement and providing weight shift reminders that are based on time since previous weight shift activities. Changes in the frequency of in-seat movement behaviors will be compared between baseline and each intervention period.
Interventions
- BEHAVIORAL Sensoria
- BEHAVIORAL AW-Shift
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2023-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04934137
The ClinicalTrials.gov registry entry for NCT04934137 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sensoria is the first listed.
NCT04934137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04934137 about?
NCT04934137 is a clinical study titled "Development of Technologies to Increase In-Seat Movement to Prevent Sitting-Acquired Pressure Injuries in Wheelchair Users". Pressure-related injuries in individuals with SCI and persons who use wheelchairs are one of the most dangerous secondary health problems encountered throughout the lifespan. With recurrence rates as high as 79% and mortality rates as high as 48% when sepsis is present, there exists a critical clini...
What is the current status of trial NCT04934137?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-03-17. Estimated completion is 2023-01-20.
What interventions are being tested in trial NCT04934137?
The interventions under investigation include: Sensoria (BEHAVIORAL), AW-Shift (BEHAVIORAL).
Who is sponsoring clinical trial NCT04934137?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.